FDA Inspection 1102904 — Southern California Permanente Medical Group IRB
The FDA completed an inspection of Southern California Permanente Medical Group IRB on August 2, 2019 in Pasadena, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 2, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Pasadena, CA (United States)
Additional Details
IRB